Innata Bio
PrivateLast Round
Series A
Mar 26, 2026
Total Funding Raised
$18.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Innata Bio is a biotechnology company that develops small molecule modulators to fine-tune the IL-6/gp130 signaling axis for the treatment of inflammatory and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innata Bio Comparables
Compare Innata Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytonics Corporation | 73% | |
| Genascence Corporation | 71% | |
| Biosplice Therapeutics | 71% |
Innata Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 26, 2026 |
Innata Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Raised $10M in Series A funding.
Innata Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Innata Bio's valuation, stock price, and market status.
Is Innata Bio a public or private company?
Innata Bio is a private company.
What is the current stock price of Innata Bio?
Innata Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Innata Bio worth (valuation)?
Valuation information for Innata Bio is not publicly available.
Can I buy Innata Bio stock?
Innata Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Innata Bio's last funding round?
Innata Bio's most recent funding round was Series A on March 26, 2026.
Who are the main investors in Innata Bio?
Key investors in Innata Bio include United States Department of Defense, National Institutes of Health (NIH).
Will Innata Bio IPO soon?
No public IPO plans have been announced for Innata Bio.
How can I track Innata Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innata Bio's secondary market activity and sign up for updates.